University of Guadalajara clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-20
What changed in the last 30 days
3 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 3 with minor changes only.
-
Minor: 2 trials marked Unknown by the registry's verification sweep Changed
- Minor: Celery Seed on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Minor: Olive Leaf Extract, Meta-inflammation, Anxiety, and Excess Weight Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Enrolling by Invitation
- Minor: Ancestry · Ancestry Supplementation · Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Primary completion pushed from Oct 2026 to Dec 2026
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Phase 2 | 3 | |
| Phase 2/3 | 1 | |
| Phase 4 | 1 |
Not charted: 6 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials
Obesity (2) · Diabetes (1) · NASH / MASH (1) · Rheumatoid Arthritis (1)
Get alerts when University of Guadalajara's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.